# A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-i-ii-study-of-rituximab-ifosfamide-mitoxantrone-andetoposide-r-ime-for-b/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robin Joyce,Meredith M. Regan,J. Ottaway,T Umiel,Jean-Pierre Tétreault,J Levine,David F. McDermott,Daire J. Hurley,Nancy Giallombardo,Terry Smith,Deborah Lamontagne,Lynne Uhl,David Avigan |
| Citations | 13 |
| DOI | 10.1093/annonc/mdg705 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2167401810 |
| PMID | 12736227 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Daire J. Hurley](https://scholariq.org/researchers/daire-j-hurley/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)

## Paper topics

- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.